标题
The role of Bruton’s tyrosine kinase in autoimmunity and implications for therapy
作者
关键词
-
出版物
Expert Review of Clinical Immunology
Volume 12, Issue 7, Pages 763-773
出版商
Informa UK Limited
发表日期
2016-02-11
DOI
10.1586/1744666x.2016.1152888
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Hypermorphic mutation of phospholipase C, 2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activation
- (2015) T.-M. Liu et al. BLOOD
- Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib
- (2015) C. Sun et al. BLOOD
- CXCL13 antibody for the treatment of autoimmune disorders
- (2015) Ekaterina Klimatcheva et al. BMC IMMUNOLOGY
- Function and regulation of self-reactive marginal zone B cells in autoimmune arthritis
- (2015) Anna-Karin E Palm et al. Cellular & Molecular Immunology
- Bruton’s Tyrosine Kinase Synergizes with Notch2 To Govern Marginal Zone B Cells in Nonobese Diabetic Mice
- (2015) James B. Case et al. JOURNAL OF IMMUNOLOGY
- Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus
- (2015) Christopher M Tipton et al. NATURE IMMUNOLOGY
- X-linked agammaglobulinemia in two siblings with a novel mutation in theBTKgene who presented with polyarticular juvenile idiopathic arthritis
- (2015) T Patiroglu et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Ibrutinib for the treatment of Waldenström macroglobulinemia
- (2015) Rajshekhar Chakraborty et al. Expert Review of Hematology
- Btk inhibition suppresses agonist-induced human macrophage activation and inflammatory gene expression in RA synovial tissue explants
- (2014) Linda M Hartkamp et al. ANNALS OF THE RHEUMATIC DISEASES
- Structural evaluation of BTK and PKCδ mediated phosphorylation of MAL at positions Tyr86 and Tyr106
- (2014) Rehan Zafar Paracha et al. COMPUTATIONAL BIOLOGY AND CHEMISTRY
- Ibrutinib: First Global Approval
- (2014) Fiona Cameron et al. DRUGS
- Bruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation
- (2014) Vassilios Lougaris et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Autoimmunity and Inflammation in X-linked Agammaglobulinemia
- (2014) Vivian P. Hernandez-Trujillo et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Dual Functions of Bruton's Tyrosine Kinase and Tec Kinase during Fc Receptor-Induced Signaling and Phagocytosis
- (2014) J. Jongstra-Bilen et al. JOURNAL OF IMMUNOLOGY
- Bruton's Tyrosine Kinase Promotes Persistence of Mature Anti-Insulin B Cells
- (2014) R. H. Bonami et al. JOURNAL OF IMMUNOLOGY
- Structure-Based Drug Design of RN486, a Potent and Selective Bruton’s Tyrosine Kinase (BTK) Inhibitor, for the Treatment of Rheumatoid Arthritis
- (2014) Yan Lou et al. JOURNAL OF MEDICINAL CHEMISTRY
- Functional characterization of BTK C481S mutation that confers ibrutinib resistance: exploration of alternative kinase inhibitors
- (2014) S Cheng et al. LEUKEMIA
- Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor Ibrutinib
- (2014) Jennifer A. Woyach et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ibrutinib Resistance in Chronic Lymphocytic Leukemia
- (2014) Richard R. Furman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pre-B Cell Receptor Signaling Induces Immunoglobulin κ Locus Accessibility by Functional Redistribution of Enhancer-Mediated Chromatin Interactions
- (2014) Ralph Stadhouders et al. PLOS BIOLOGY
- Suppression of Glomerulonephritis in Lupus-Prone NZB × NZW Mice by RN486, a Selective Inhibitor of Bruton's Tyrosine Kinase
- (2013) Paola Mina-Osorio et al. ARTHRITIS AND RHEUMATISM
- Egress of CD19+CD5+ cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients
- (2013) B. Y. Chang et al. BLOOD
- Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes
- (2013) J. A. Dubovsky et al. BLOOD
- Effects of CXCL13 inhibition on lymphoid follicles in models of autoimmune disease
- (2013) Donna K. Finch et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Bruton's tyrosine kinase regulates TLR9 but not TLR7 signaling in human plasmacytoid dendritic cells
- (2013) Jingming Wang et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Specific peripheral B cell tolerance defects in patients with multiple sclerosis
- (2013) Tuure Kinnunen et al. JOURNAL OF CLINICAL INVESTIGATION
- Ibrutinib and novel BTK inhibitors in clinical development
- (2013) Akintunde Akinleye et al. Journal of Hematology & Oncology
- Selective Inhibition of BTK Prevents Murine Lupus and Antibody-Mediated Glomerulonephritis
- (2013) A. L. Rankin et al. JOURNAL OF IMMUNOLOGY
- Tolerant Anti-Insulin B Cells Are Effective APCs
- (2013) P. L. Kendall et al. JOURNAL OF IMMUNOLOGY
- Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial
- (2013) Susan O'Brien et al. LANCET ONCOLOGY
- Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
- (2013) John C. Byrd et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel small molecule therapeutics in rheumatoid arthritis
- (2013) V. Kelly et al. RHEUMATOLOGY
- Inhibitors of BTK and ITK: State of the New Drugs for Cancer, Autoimmunity and Inflammatory Diseases
- (2013) L. Vargas et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- IL-10-producing regulatory B cells (B10 cells) in autoimmune disease
- (2013) Ioannis Kalampokis et al. ARTHRITIS RESEARCH & THERAPY
- Bruton’s Tyrosine Kinase (BTK) Inhibitors in Clinical Trials
- (2013) Jan A. Burger Current Hematologic Malignancy Reports
- Expansion of Autoreactive Unresponsive CD21−/lowB Cells in Sjögren's Syndrome-Associated Lymphoproliferation
- (2012) D. Saadoun et al. ARTHRITIS AND RHEUMATISM
- Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice
- (2012) L. P. Kil et al. BLOOD
- Tyrosine kinase inhibitors as potential drugs for B-cell lymphoid malignancies and autoimmune disorders
- (2012) Tadeusz Robak et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Increased Pro-inflammatory Cytokine Production After Lipopolysaccharide Stimulation in Patients with X-linked Agammaglobulinemia
- (2012) María Edith González-Serrano et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies
- (2012) Ranjana H. Advani et al. JOURNAL OF CLINICAL ONCOLOGY
- Modulating proximal cell signaling by targeting Btk ameliorates humoral autoimmunity and end-organ disease in murine lupus
- (2012) Jack Hutcheson et al. ARTHRITIS RESEARCH & THERAPY
- Anergic Responses Characterize a Large Fraction of Human Autoreactive Naive B Cells Expressing Low Levels of Surface IgM
- (2011) T. D. Quach et al. JOURNAL OF IMMUNOLOGY
- Antiarthritis Effect of a Novel Bruton's Tyrosine Kinase (BTK) Inhibitor in Rat Collagen-Induced Arthritis and Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling: Relationships between Inhibition of BTK Phosphorylation and Efficacy
- (2011) L. Liu et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk
- (2011) Xingguang Liu et al. NATURE IMMUNOLOGY
- More than just B-cell inhibition
- (2011) Eric M Ruderman et al. ARTHRITIS RESEARCH & THERAPY
- The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells
- (2011) Betty Y Chang et al. ARTHRITIS RESEARCH & THERAPY
- The Role of Bruton's Tyrosine Kinase in B-Cell Development and Function in Mice and Mana
- (2010) WASIF N. KHAN et al. Annals of the New York Academy of Sciences
- Genes on the X chromosome affect development of collagen-induced arthritis in mice
- (2010) L. JANSSON et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Constitutive activation of Bruton's tyrosine kinase induces the formation of autoreactive IgM plasma cells
- (2010) Rogier Kersseboom et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- CXCL13 Blockade Disrupts B Lymphocyte Organization in Tertiary Lymphoid Structures without Altering B Cell Receptor Bias or Preventing Diabetes in Nonobese Diabetic Mice
- (2010) R. A. Henry et al. JOURNAL OF IMMUNOLOGY
- Specific Btk inhibition suppresses B cell– and myeloid cell–mediated arthritis
- (2010) Julie A Di Paolo et al. Nature Chemical Biology
- The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy
- (2010) L. A. Honigberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reduced Diabetes in btk-Deficient Nonobese Diabetic Mice and Restoration of Diabetes with Provision of an Anti-Insulin IgH Chain Transgene
- (2009) P. L. Kendall et al. JOURNAL OF IMMUNOLOGY
- Btk regulates localization, in vivo activation, and class switching of anti-DNA B cells
- (2008) Kristina E. Halcomb et al. MOLECULAR IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now